EPCAM and cancer: Targeting EpCAM to capture CTC was a proven successful strategy by numerous clinical CTC studies on thousands of cancer patients demonstrating the prognostic relevance of EpCAM (+) CytoKeratins (+) CTCs in breast, prostate, lung or colorectal cancers, and other epithelial tumors, as reviewed elsewhere [99, 100].